Plasma EV profiling facilitates low abundance biomarker discovery in pancreatic cancer

被引：1
|
作者：
Bansal, Shivani
Wang, Shu
Li, Yaoxiang
Bansal, Sunil
Smith, Jill
Tyburski, John B.
Unger, Keith
Cheema, Amrita
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1074
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1074
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer
    Du, Yan
    Yao, Kai
    Feng, Qingbo
    Mao, Feiyu
    Xin, Zechang
    Xu, Peng
    Yao, Jie
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [32] Plasma proteomics invitation to cervical cancer potential biomarker discovery
    Kim, H.
    Kim, N.
    Kim, Y. N.
    Jeong, D. H.
    Lee, D. S.
    Kim, K. T.
    Youm, J. B.
    Park, W. S.
    Warda, M.
    Kang, S.
    Kim, T. H.
    Prince, A. -E. B.
    Kim, E.
    Han, J.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S213 - S213
  • [33] Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer
    Kuhlmann, Koert F. D.
    van Till, J. W. Olivier
    Boermeester, Marja A.
    de Reuver, Philip R.
    Tzvetanova, Iva D.
    Offerhaus, G. Johan A.
    ten Kate, Fiebo J. W.
    Busch, Olivier R. C.
    van Gulik, Thomas M.
    Gouma, Dirk J.
    Crawford, Howard C.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (05) : 886 - 891
  • [34] Profiling Extracellular Long RNA Transcriptome in Human Plasma and Extracellular Vesicles for Biomarker Discovery
    Rodosthenous, Rodosthenis S.
    Hutchins, Elizabeth
    Reiman, Rebecca
    Yeri, Ashish S.
    Srinivasan, Srimeenakshi
    Whitsett, Timothy G.
    Ghiran, Ionita
    Silverman, Michael G.
    Laurent, Louise C.
    Van Keuren-Jensen, Kendall
    Das, Saumya
    ISCIENCE, 2020, 23 (06)
  • [35] Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery
    Mikdadi, Dina
    O'Connell, Kyle A.
    Meacham, Philip J.
    Dugan, Madeleine A.
    Ojiere, Michael O.
    Carlson, Thaddeus B.
    Klenk, Juergen A.
    CANCER BIOMARKERS, 2022, 33 (02) : 173 - 184
  • [36] METHODOLOGY OF PANCREATIC JUICE COLLECTION FROM THE DUODENUM FOR BIOMARKER DISCOVERY AND EARLY DETECTION OF PANCREATIC CANCER
    Levink, Iris J.
    Nesteruk, Kateryna
    Visser, D. I.
    Sieuwerts, A. M.
    Fernandes, Celio J.
    Jansen, M. P. H. M.
    Peppelenbosch, Maikel
    Cahen, D. L.
    Fuhler, Gwenny
    Bruno, Marco J.
    GASTROENTEROLOGY, 2020, 158 (06) : S1136 - S1136
  • [37] Fast quantitative urinary proteomic profiling workflow for biomarker discovery in kidney cancer
    Lin, Lin
    Yu, Quan
    Zheng, Jiaxin
    Cai, Zonglong
    Tian, Ruijun
    CLINICAL PROTEOMICS, 2018, 15
  • [38] Fast quantitative urinary proteomic profiling workflow for biomarker discovery in kidney cancer
    Lin Lin
    Quan Yu
    Jiaxin Zheng
    Zonglong Cai
    Ruijun Tian
    Clinical Proteomics, 2018, 15
  • [39] Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer
    Foukakis, Theodoros
    Lovrot, John
    Sandqvist, Patricia
    Xie, Hanjing
    Lindstrom, Linda S.
    Giorgetti, Carla
    Jacobsson, Hans
    Hedayati, Elham
    Bergh, Jonas
    MOLECULAR ONCOLOGY, 2015, 9 (07) : 1384 - 1391
  • [40] Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer
    Dive, C.
    Smith, R. A.
    Garner, E.
    Ward, T.
    St George-Smith, S.
    Campbell, F.
    Greenhalf, W.
    Ghaneh, P.
    Neoptolemos, J. P.
    BRITISH JOURNAL OF CANCER, 2010, 102 (03) : 577 - 582
12345